Clinical Trial Innovation Pioneer Craig Lipset Joins Spencer Health Solutions Advisory Board
Retrieved on:
Tuesday, October 5, 2021
Pharmaceutical, Health, Clinical Trials, Medical Devices, Medicine, Clinical trial, Compliance, Patient, Pharmacy, Health status of Asian Americans, Seymour Martin Lipset, Telehealth, Twitter, Patient safety, COVID-19, Research, Drug development, Guest appearance, Industry, Pharmaceutical industry, Hospital
Craig Lipset, a pioneer in clinical trial innovation for Pfizer, has joined the Spencer Health Solutions advisory board.
Key Points:
- Craig Lipset, a pioneer in clinical trial innovation for Pfizer, has joined the Spencer Health Solutions advisory board.
- Lipset is an active advisor for pharmaceutical companies, technology leaders, and investors seeking to identify and scale innovative solutions for clinical trials.
- He previously led clinical trial innovation for Pfizer and was an advisor for venture capital investments.
- "Now is the time to deliver the future of clinical trials, accelerate drug development and improve the lives of patients," Lipset said.